Research ArticleOpen accessAll words, across the recordRibavirin Plus Therapy in Covid-19-A Single-Center ExperienceBudha Oinam Singh, Gaurav Chikara, Prasan Kumar Panda et al.COVID-19 infection has a similar clinical spectrum of disease presentation such as SARS and MERS in the past. These led to the assumption of the possibility to treat COVID-19 infection with antivirals which had been used to treat SARS and MERS. A retrospective analysis was done in symptomatic adult patients of COVID-19 infection to explore whether ribavirin antiviral combinations reduce … …American Journal of Pharmacology and Toxicology, Vol. 18, Issue 1 · 25 Jul 2023 · 8,613 accessesView PDFCite
Research ArticleOpen accessAll words, across the recordAssociation of Remdesivir with Poor Clinical Outcomes in COVID-19-A Single Center ExperienceRajat Ranka, Arjun, Prasan Kumar Panda et al.The need for an antiviral against COVID-19 prompted clinical trials worldwide and based on initial promising trends, remdesivir was widely used, including in India (compassionate use). Subsequent trials have been conflicting in their results and the utility of the drug has been widely debated. This is a record-based retrospective cohort study in a 1000-bedded government teaching hospital in North India. … …American Journal of Pharmacology and Toxicology, Vol. 17, Issue 1 · 3 Jun 2022 · 7,212 accessesView PDFCite
Research ArticleOpen accessAll words, across the recordA Fuzzy Approach for Integrated Measure of Object-Oriented Software TestabilityVandana Gupta, K. K. Aggarwal, Yogesh SinghFor large software systems, testing phase seems to have profound effect on the overall acceptability and quality of the final product. The success of this activity can be judged by measuring the testability of the software. A good measure for testability can better manage the testing effort and time. Different Object Oriented Metrics are used in measurement of object-oriented testability … …Journal of Computer Science, Vol. 1, Issue 2 · 30 Jun 2005 · 7,907 accessesView PDFCite